BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 30943404)

  • 1. HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma.
    Miska J; Lee-Chang C; Rashidi A; Muroski ME; Chang AL; Lopez-Rosas A; Zhang P; Panek WK; Cordero A; Han Y; Ahmed AU; Chandel NS; Lesniak MS
    Cell Rep; 2019 Apr; 27(1):226-237.e4. PubMed ID: 30943404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through HIF-1α accumulation.
    Fan Y; Potdar AA; Gong Y; Eswarappa SM; Donnola S; Lathia JD; Hambardzumyan D; Rich JN; Fox PL
    Nat Cell Biol; 2014 May; 16(5):445-56. PubMed ID: 24747440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced glycolysis and HIF-1α activation in adipose tissue macrophages sustains local and systemic interleukin-1β production in obesity.
    Sharma M; Boytard L; Hadi T; Koelwyn G; Simon R; Ouimet M; Seifert L; Spiro W; Yan B; Hutchison S; Fisher EA; Ramasamy R; Ramkhelawon B; Moore KJ
    Sci Rep; 2020 Mar; 10(1):5555. PubMed ID: 32221369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres.
    Méndez O; Zavadil J; Esencay M; Lukyanov Y; Santovasi D; Wang SC; Newcomb EW; Zagzag D
    Mol Cancer; 2010 Jun; 9():133. PubMed ID: 20515450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of HIF-1α Knockout Primary Human Natural Killer Cells Including Populations in Allogeneic Glioblastoma.
    Nakazawa T; Morimoto T; Maeoka R; Yamada K; Matsuda R; Nakamura M; Nishimura F; Yamada S; Park YS; Tsujimura T; Nakagawa I
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geranylgeranyltransferase I regulates HIF-1α promoting glioblastoma cell migration and invasion.
    Zhou X; Liu Z; Shi Q; Jiao J; Bian W; Song X; Mo J; Sang B; Xu Y; Qian J; Chao Y; Yu R
    J Neurooncol; 2013 May; 112(3):365-74. PubMed ID: 23475391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment.
    Nigim F; Cavanaugh J; Patel AP; Curry WT; Esaki S; Kasper EM; Chi AS; Louis DN; Martuza RL; Rabkin SD; Wakimoto H
    J Neuropathol Exp Neurol; 2015 Jul; 74(7):710-22. PubMed ID: 26083570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
    Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K
    Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodal regulates energy metabolism in glioma cells by inducing expression of hypoxia-inducible factor 1α.
    Lai JH; Jan HJ; Liu LW; Lee CC; Wang SG; Hueng DY; Cheng YY; Lee HM; Ma HI
    Neuro Oncol; 2013 Oct; 15(10):1330-41. PubMed ID: 23911596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-κB signaling pathway.
    Jin P; Shin SH; Chun YS; Shin HW; Shin YJ; Lee Y; Kim D; Nam DH; Park JW
    Oncogene; 2018 Jun; 37(23):3070-3087. PubMed ID: 29535421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity.
    Hsieh CH; Lee CH; Liang JA; Yu CY; Shyu WC
    Oncol Rep; 2010 Dec; 24(6):1629-36. PubMed ID: 21042761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
    Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
    Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor-2α (HIF-2α), but not HIF-1α, is essential for hypoxic induction of class III β-tubulin expression in human glioblastoma cells.
    Bordji K; Grandval A; Cuhna-Alves L; Lechapt-Zalcman E; Bernaudin M
    FEBS J; 2014 Dec; 281(23):5220-36. PubMed ID: 25244496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF1-positive and HIF1-negative glioblastoma cells compete in vitro but cooperate in tumor growth in vivo.
    Fiorenzo P; Mongiardi MP; Dimitri D; Cozzolino M; Ferri A; Montano N; Trevisi G; Maira G; Battistini L; Falchetti ML; Levi A; Pallini R
    Int J Oncol; 2010 Apr; 36(4):785-91. PubMed ID: 20198320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time- and oxygen-dependent expression and regulation of NDRG1 in human brain cancer cells.
    Said HM; Safari R; Al-Kafaji G; Ernestus RI; Löhr M; Katzer A; Flentje M; Hagemann C
    Oncol Rep; 2017 Jun; 37(6):3625-3634. PubMed ID: 28498432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Hypoxia-Inducible Factor-1α/Pyruvate Dehydrogenase Kinase 1 Axis by Dichloroacetate Suppresses Bleomycin-induced Pulmonary Fibrosis.
    Goodwin J; Choi H; Hsieh MH; Neugent ML; Ahn JM; Hayenga HN; Singh PK; Shackelford DB; Lee IK; Shulaev V; Dhar S; Takeda N; Kim JW
    Am J Respir Cell Mol Biol; 2018 Feb; 58(2):216-231. PubMed ID: 28915065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis.
    Ge X; Pan MH; Wang L; Li W; Jiang C; He J; Abouzid K; Liu LZ; Shi Z; Jiang BH
    Cell Death Dis; 2018 Nov; 9(11):1128. PubMed ID: 30425242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
    Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
    Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.
    Yao Y; Wang L; Zhou J; Zhang X
    J Transl Med; 2017 Feb; 15(1):28. PubMed ID: 28183349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hijacking Sexual Immuno-Privilege in GBM-An Immuno-Evasion Strategy.
    Sharpe MA; Baskin DS; Jenson AV; Baskin AM
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.